Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Journal of Chemical Education|September 18, 2023
Generating Publishable Data from Course-Based Undergraduate Research Experiences in ChemistryAmanda L Wolfe, P Ryan SteedChemistry (Weinheim an Der Bergstrasse, Germany)|October 24, 2008
Synthesis and antibiofilm activity of a second-generation reverse-amide oroidin library: a structure-activity relationship studyT Eric Ballard, Justin J Richards, Amanda L Wolfe, et al.Bioorganic & Medicinal Chemistry Letters|August 29, 2022
Total synthesis and antibacterial evaluation of Empetroxepins A and B and related analogsKyle E Murphy, Marcia K Thacher, Erin C Young, et al.Cancer Biology & Therapy|June 14, 2013
Evaluation of a reductively activated duocarmycin prodrug against murine and human solid cancersGeorge A Vielhauer, Megan Swink, Nikhil K Parelkar, et al.Journal of Medicinal Chemistry|August 16, 2013
A fundamental relationship between hydrophobic properties and biological activity for the duocarmycin class of DNA-alkylating antitumor drugs: hydrophobic-binding-driven bondingAmanda L Wolfe, Katharine K Duncan, James P Lajiness, et al.Journal of Medicinal Chemistry|May 1, 2013
Efficacious cyclic N-acyl O-amino phenol duocarmycin prodrugsAmanda L Wolfe, Katharine K Duncan, Nikhil K Parelkar, et al.Chemmedchem|October 8, 2023
Bisbenzamidine and Bisbenzguanidine Ureas Act as Antibacterial Agents against Pseudomonas aeruginosaCasey N Kellogg, Bryce A Pugh, Isaak M Starr, et al.Future Medicinal Chemistry|October 30, 2020
Advances in antibiotic drug discovery: reducing the barriers for antibiotic developmentKyle E Murphy, Grace F Sloan, Grace V Lawhern, et al.Journal of Medicinal Chemistry|June 2, 2012
A novel, unusually efficacious duocarmycin carbamate prodrug that releases no residual byproductAmanda L Wolfe, Katharine K Duncan, Nikhil K Parelkar, et al.Pageof 2